Additionally, it assesses the impact of rs2836882 on ETS2 gene expression in PBMCs and incorporates this variant into a comprehensive genetic risk profile, combining it with other known SLE-associated polymorphisms. This evidence concerns the gene ETS2 and systemic lupus erythematosus.